Amine derivative having npy y5 receptor antagonist activity...

Details Amine derivative having npy y5 receptor antagonist activity... Amine derivative having npy y5 receptor antagonist activity...

A - Human Necessities

61

K

A61K 31/18 (2006.01) A61K 31/40 (2006.01) A61K 31/4015 (2006.01) A61K 31/415 (2006.01) A61K 31/4164 (2006.01) A61K 31/42 (2006.01) A61K 31/423 (2006.01) A61K 31/425 (2006.01) A61K 31/426 (2006.01) A61K 31/428 (2006.01) A61K 31/44 (2006.01) A61K 31/445 (2006.01) A61K 31/47 (2006.01) A61K 31/495 (2006.01) A61K 31/50 (2006.01) A61K 31/505 (2006.01) A61K 31/5375 (2006.01) A61K 31/5377 (2006.01) A61K 31/538 (2006.01) A61K 31/553 (2006.01) A61P 3/04 (2006.01) A61P 43/00 (2006.01) C07D 211/14 (2006.01) C07D 213/74

Patent

CA 2703797

This invention provides an anorectic or anti-obesity composition comprising a compound of the formula (I): formula (I): (see formula I) a pharmaceutically acceptable salt or solvate thereof, wherein R1 is optionally substituted lower alkyl, Y is -S(O)n- wherein n is 1 or 2, or -CO-, R2 is hydrogen or lower alkyl, R7 is hydrogen or lower alkyl, X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, and Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.

L'invention porte sur un coupe-faim ou agent anti-obésité contenant un composé représenté par la formule (I) ci-après, un sel pharmaceutiquement acceptable de celui-ci ou un solvate de n'importe lequel d'entre eux. (Dans la formule, R1 représente un alkyle inférieur facultativement substitué; Y représente -S(O)n- (où n est 1 ou 2) ou -CO-; R2 représente un hydrogène ou un alkyle inférieur; R7 représente un hydrogène ou un alkyle inférieur; X représente un alkylène inférieur, un alcénylène inférieur, un arylène, un cycloalkylène ou similaires; et Z représente un alkyle inférieur, un groupe hydrocarboné cyclique facultativement substitué, un groupe hétérocyclique facultativement substitué ou similaires).

Affiliated with

Also associated with

Rating

Amine derivative having npy y5 receptor antagonist activity... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amine derivative having npy y5 receptor antagonist activity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amine derivative having npy y5 receptor antagonist activity... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1589128